Kathryn L Gilroy

15PUBLICATIONS
180CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 06, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Nov 04, 2025
WNT signalling promotes NF-κB activation and drug resistance in KRAS-mutant colorectal cancer.

Bojie Cong, Evangelia Stamou, Kathryn Pennel

|Jun 16, 2025
In Vivo Labeling Resolves Distinct Temporal, Spatial, and Functional Properties of Tumor Macrophages and Identifies Subset-Specific Effects of PD-L1 Blockade.

Colin Y C Lee, Isaac Dean, Nathan Richoz

|Dec 05, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.

Catriona A Ford, Dana Koludrovic, Patricia P Centeno

Pageof 3

Frequent Collaborators

11 joint publications

Owen J Sansom

9 joint publications

Andrew D Campbell

8 joint publications

Colin Nixon

7 joint publications

Philip D Dunne